Results of Lumega-Z Data to be Presented at ARVO

Source: Guardion Health Sciences

Guardion Health Sciences Scientific Advisory Board member William Sponsel, MD, will be presenting an abstract at the Association for Research in Vision and Ophthalmology (ARVO) 2019 Annual Meeting in Vancouver, Canada, which will be held from April 28, 2019 to May 2, 2019. The abstract is titled “Effect of oral Lumega-Z on pericentral FDT function in IOP-stabilized severe glaucoma” and has been made available on ARVO’s website at https://www.arvo.org/annual-meeting/program/online-planner/

The study assessed the potential utility of the company’s medical food product, Lumega-Z, which is designed to restore the macular protective pigment layer. The abstract concludes that in patients who had ordered 12 consecutive month’s supply of Lumega-Z, Lumega-Z treatment was associated with significant improvement in visual field function among patients with severe glaucoma who had previously shown degeneration despite having had excellent intraocular pressure control.

The study was conducted at (i) the School of Medicine, Universidad Autonoma de Guadalajara in Guadalajara, Mexico, (ii) the Visual Sciences/Biomedical Engineering, UIW/UTSA in San Antonio, Texas, and (iii) the Ophthalmology Department of the New York Medical College.

Related Content